Which hedge funds own NUVB? NUVATION BIO INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in NUVB (NUVATION BIO INC) in their Q2 2026 13F filings, worth $66.5m in total. The largest holder by portfolio weight is Duquesne Family Office LLC at 0.6% of its book. 3 exited: Brevan Howard Capital Management, Farallon Capital Management, Tudor Investment.
8tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold NUVB? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Duquesne Family Office LLC | Q2 2026 | 0.6% | $25.8m | 4,539,800 | 0% | held |
| Abrams Capital Management | Q2 2026 | 0.1% | $7.2m | 1,270,504 | 0% | held |
| Woodline Partners | Q2 2026 | 0.0% | $5.5m | 975,532 | 2% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $7.6m | 1,345,995 | 141% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $11.3m | 1,988,330 | -4% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $6.5m | 1,140,000 | 190% | added |
| Millennium Management | Q2 2026 | 0.0% | $2.1m | 372,858 | -67% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $473.7k | 83,402 | -19% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $225.9k |
| Farallon Capital Management | 0.0% | $124.4k |
| Tudor Investment | 0.0% | $760.4k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
| Greenlight Capital | Q4 2023 | 0.0% |
How has hedge fund ownership of NUVB changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $66.5m |
| Q1 2026 | 11 | $48.4m |
| Q4 2025 | 4 | $43.2m |
| Q3 2025 | 2 | $17.6m |
| Q2 2025 | 2 | $7.5m |
| Q1 2025 | 2 | $7.5m |
| Q4 2024 | 4 | $12.4m |
| Q3 2024 | 4 | $11.9m |
| Q2 2024 | 3 | $13.4m |
| Q1 2024 | 2 | $17.4m |
| Q4 2023 | 3 | $8.0m |
| Q3 2023 | 3 | $5.7m |
| Q2 2023 | 3 | $7.5m |
| Q1 2023 | 5 | $9.3m |
| Q4 2022 | 5 | $21.0m |
| Q3 2022 | 5 | $39.0m |
Counts every tracked manager that disclosed NUVB in that quarter's filing, including managers that have since stopped filing.